Ann: NDA Resubmission Accepted and Approval Date Confirmed, page-62

I think the next catalyst is the next Kaken quarterly, which will show further increased sales and might see us gain a few cents. Then the FDA decision itself in late June is another catalyst - I'm not sure how significant that will actually be - hopefully a 50-100% increase in SP, but who knows for sure. Then a few months later will be what I think will be the biggest catalyst of the lot - demonstrated sales and take-up in the market. That's when the figures will start getting crunched and confirmed, so it goes without saying that getting to a $ sign all hinges on early sales performance.